×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACET – adicet bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACET
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
05:49 am
acet
Adicet Bio (ACET) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
Adicet Bio (ACET) was upgraded by Truist Financial Corporation to "strong-buy".
3/23
08:04 am
acet
Adicet Bio (ACET) had its price target lowered by HC Wainwright from $50.00 to $27.00. They now have a "buy" rating on the stock.
Low
Report
Adicet Bio (ACET) had its price target lowered by HC Wainwright from $50.00 to $27.00. They now have a "buy" rating on the stock.
3/12
04:00 pm
acet
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
Low
Report
Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
1/30
08:01 am
acet
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
Medium
Report
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
1/30
07:00 am
acet
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
Medium
Report
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
1/29
06:16 am
acet
Adicet Bio (NASDAQ:ACET) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Adicet Bio (NASDAQ:ACET) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
1/21
07:17 am
acet
Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Adicet Bio (NASDAQ:ACET) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Date
Time
Symbol
Headline
Impact
4/10
08:28 pm
acet
Form SCHEDULE 13D/A Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Neutral
Report
Form SCHEDULE 13D/A Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
4/9
05:39 pm
acet
Form 4 Adicet Bio, Inc. For: Apr 07 Filed by: OrbiMed Capital GP VI LLC
Low
Report
Form 4 Adicet Bio, Inc. For: Apr 07 Filed by: OrbiMed Capital GP VI LLC
4/9
05:35 pm
acet
Form 144 Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Low
Report
Form 144 Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
4/8
08:14 pm
acet
Form 144 Adicet Bio, Inc. Filed by: OrbiMed Advisors Israel II Ltd
Medium
Report
Form 144 Adicet Bio, Inc. Filed by: OrbiMed Advisors Israel II Ltd
4/7
08:46 pm
acet
Form 144 Adicet Bio, Inc. Filed by: OrbiMed Israel GP Ltd.
Low
Report
Form 144 Adicet Bio, Inc. Filed by: OrbiMed Israel GP Ltd.
3/27
04:15 pm
acet
Form 4 Adicet Bio, Inc. For: Mar 25 Filed by: Harvey Brian Nicholas
Medium
Report
Form 4 Adicet Bio, Inc. For: Mar 25 Filed by: Harvey Brian Nicholas
3/27
04:12 pm
acet
Form 4 Adicet Bio, Inc. For: Mar 25 Filed by: Schor Chen
Medium
Report
Form 4 Adicet Bio, Inc. For: Mar 25 Filed by: Schor Chen
3/27
04:11 pm
acet
Form 4 Adicet Bio, Inc. For: Mar 25 Filed by: Maltzman Julia D.
Medium
Report
Form 4 Adicet Bio, Inc. For: Mar 25 Filed by: Maltzman Julia D.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: